Advertisement
Advertisement

BWAY

BWAY logo

Brainsway Ltd. - ADR

16.73
USD
Sponsored
-0.44
-2.56%
May 11, 16:00 UTC -4
Closed
exchange

After-Market

17.05

+0.32
+1.89%

BWAY Earnings Reports

Positive Surprise Ratio

BWAY beat 12 of 17 last estimates.

71%

Next Report

In 2 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$49.14M
/
$0.17
Implied change from Q4 25 (Revenue/ EPS)
+4.13%
/
-34.62%
Implied change from Q1 25 (Revenue/ EPS)
+18.09%
/
+142.86%

Brainsway Ltd. - ADR earnings per share and revenue

On Mar 11, 2026, BWAY reported earnings of 0.26 USD per share (EPS) for Q4 25, beating the estimate of 0.13 USD, resulting in a 98.02% surprise. Revenue reached 47.19 million, compared to an expected 46.13 million, with a 2.30% difference. The market reacted with a +8.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.17 USD, with revenue projected to reach 49.14 million USD, implying an decrease of -34.62% EPS, and increase of 4.13% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
logo
CeriBell, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.39
Actual
-$0.52
Surprise
-30.72%
logo
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
logo
Accendra Health, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.04
Surprise
+60.90%
logo
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
logo
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
logo
Exagen Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.17
Surprise
+27.87%
logo
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
logo
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
logo
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
FAQ
For Q4 2025, Brainsway Ltd. - ADR reported EPS of $0.26, beating estimates by 98.02%, and revenue of $47.19M, 2.3% above expectations.
The stock price moved up 8.34%, changed from $12.71 before the earnings release to $13.77 the day after.
The next earning report is scheduled for May 13, 2026.
Based on 3 analysts, Brainsway Ltd. - ADR is expected to report EPS of $0.17 and revenue of $49.14M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement